Renaissance Capital logo

SCYNEXIS Priced, Nasdaq: SCYX

Biotech developing treatments for life-threatening fungal infections.

Industry: Health Care

First Day Return: -10.0%

Industry: Health Care

Biotech developing treatments for life-threatening fungal infections.
more less
IPO Data
IPO File Date 02/27/2014
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 6.2
Deal Size ($mm) $62
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 05/01/2014
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $62
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Durham, NC, United States
Founded 1999
Employees at IPO 90
Website www.scynexis.com

SCYNEXIS (SCYX) Performance